Posted by ABMN Staff on Mar 19th, 2024
TD Cowen assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research note released on Monday, Marketbeat Ratings reports. The firm issued an outperform rating on the stock.
Separately, Oppenheimer...
More of this article »